As of 2025-07-02, the Relative Valuation of Sangamo Therapeutics Inc (SGMO) is (15.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.54 USD, the upside of Sangamo Therapeutics Inc based on Relative Valuation is -3036.0%.
The range of the Relative Valuation is (13.23) - (15.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.9x - 28.7x | 26.3x |
| Forward P/E multiples | 24.5x - 40.5x | 31.9x |
| Fair Price | (13.23) - (15.55) | (15.74) |
| Upside | -2567.8% - -2999.6% | -3036.0% |
| Date | P/E |
| 2025-07-01 | -0.99 |
| 2025-06-30 | -1.00 |
| 2025-06-27 | -1.00 |
| 2025-06-26 | -1.03 |
| 2025-06-25 | -1.08 |
| 2025-06-24 | -0.95 |
| 2025-06-23 | -0.80 |
| 2025-06-20 | -0.85 |
| 2025-06-18 | -0.91 |
| 2025-06-17 | -0.89 |
| 2025-06-16 | -0.92 |
| 2025-06-13 | -0.91 |
| 2025-06-12 | -0.93 |
| 2025-06-11 | -0.96 |
| 2025-06-10 | -0.95 |
| 2025-06-09 | -0.94 |
| 2025-06-06 | -0.98 |
| 2025-06-05 | -0.91 |
| 2025-06-04 | -0.91 |
| 2025-06-03 | -0.92 |
| 2025-06-02 | -0.87 |
| 2025-05-30 | -0.86 |
| 2025-05-29 | -0.85 |
| 2025-05-28 | -0.84 |
| 2025-05-27 | -0.84 |
| 2025-05-23 | -0.87 |
| 2025-05-22 | -0.91 |
| 2025-05-21 | -0.92 |
| 2025-05-20 | -0.92 |
| 2025-05-19 | -0.92 |
| 2025-05-16 | -0.87 |
| 2025-05-15 | -0.83 |
| 2025-05-14 | -0.81 |
| 2025-05-13 | -0.85 |
| 2025-05-12 | -1.38 |
| 2025-05-09 | -1.29 |
| 2025-05-08 | -1.33 |
| 2025-05-07 | -1.20 |
| 2025-05-06 | -1.13 |
| 2025-05-05 | -1.33 |
| 2025-05-02 | -1.35 |
| 2025-05-01 | -1.37 |
| 2025-04-30 | -1.43 |
| 2025-04-29 | -1.33 |
| 2025-04-28 | -1.37 |
| 2025-04-25 | -1.45 |
| 2025-04-24 | -1.51 |
| 2025-04-23 | -1.39 |
| 2025-04-22 | -1.43 |
| 2025-04-21 | -1.36 |